Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01063075
Title A Study in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company

Advanced Solid Tumor


Carboplatin + Cetuximab + Fluorouracil

Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.